136 related articles for article (PubMed ID: 8301055)
1. Interferon-alpha increases prostaglandin E2 production by cultured liver biopsy in patients with chronic viral hepatitis: can non-steroidal anti-inflammatory drugs improve the therapeutic response to interferon?
Andreone P; Cursaro C; Gasbarrini G
J Hepatol; 1993 Sep; 19(2):228-31. PubMed ID: 8301055
[TBL] [Abstract][Full Text] [Related]
2. Histological behaviour of chronic hepatitis in patients treated with alpha interferon.
Villari D; Raimondo G; Freni MA; Rodinò G; Aiello A; Fava A; Longo G; Batolo D
Pathology; 1992 Oct; 24(4):243-6. PubMed ID: 1289764
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation.
Farinati F; Cardin R; D'Errico A; De Maria N; Naccarato R; Cecchetto A; Grigioni W
Hepatology; 1996 Jun; 23(6):1468-75. PubMed ID: 8675166
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of intercellular adhesion molecule 1 on hepatocytes in viral chronic hepatitis treated with interferon alfa-2b.
García-Monzón C; García-Buey L; García-Sánchez A; Pajares JM; Moreno-Otero R
Gastroenterology; 1993 Aug; 105(2):462-9. PubMed ID: 7687575
[TBL] [Abstract][Full Text] [Related]
5. Effects of subchronic treatment with natural human interferons on antipyrine clearance and liver function in patients with chronic hepatitis.
Echizen H; Ohta Y; Shirataki H; Tsukamoto K; Umeda N; Oda T; Ishizaki T
J Clin Pharmacol; 1990 Jun; 30(6):562-7. PubMed ID: 2113064
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with interferon-alpha and ribavirin in patients with dual hepatitis B and hepatitis C virus infection.
Hung CH; Lee CM; Lu SN; Wang JH; Tung HD; Chen CH; Changchien CS
J Gastroenterol Hepatol; 2005 May; 20(5):727-32. PubMed ID: 15853986
[TBL] [Abstract][Full Text] [Related]
7. [Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure].
Vallet-Pichard A; Pol S
Nephrol Ther; 2015 Nov; 11(6):507-20. PubMed ID: 26423779
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta 1: in situ expression in the liver of patients with chronic hepatitis C treated with alpha interferon.
Bedossa P; Poynard T; Mathurin P; Lemaigre G; Chaput JC
Gut; 1993; 34(2 Suppl):S146-7. PubMed ID: 8314486
[TBL] [Abstract][Full Text] [Related]
9. Changes in serum and histology of patients with chronic hepatitis B after interferon alpha-2b treatment.
Han HL; Lang ZW
World J Gastroenterol; 2003 Jan; 9(1):117-21. PubMed ID: 12508364
[TBL] [Abstract][Full Text] [Related]
10. Exacerbation of psoriasis due to interferon-alpha treatment of chronic active hepatitis.
Georgetson MJ; Yarze JC; Lalos AT; Webster GF; Martin P
Am J Gastroenterol; 1993 Oct; 88(10):1756-8. PubMed ID: 8213720
[TBL] [Abstract][Full Text] [Related]
11. Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study Group.
Niederau C; Strohmeyer G; Heintges T; Peter K; Göpfert E
Hepatogastroenterology; 1998; 45(21):797-804. PubMed ID: 9684137
[TBL] [Abstract][Full Text] [Related]
12. Chronic hepatitis in patients with active hepatitis B virus and hepatitis C virus combined infections: a histological study.
Villari D; Pernice M; Spinella S; Squadrito G; Rodinò G; Brancatelli S; Longo G; Raimondo G
Am J Gastroenterol; 1995 Jun; 90(6):955-8. PubMed ID: 7771429
[TBL] [Abstract][Full Text] [Related]
13. [Investigation of oxidative stress and antioxidant defense in patients with hepatitis B virus infection and the effect of interferon-alpha plus lamivudine combination therapy on oxidative stress].
Acar A; Görenek L; Aydin A; Eyigün CP; Eken A; Sayal A; Pahsa A
Mikrobiyol Bul; 2009 Jul; 43(3):411-23. PubMed ID: 19795616
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical evidence of lactoferrin in hepatic biopsies of patients with viral or cryptogenetic chronic liver disease.
Tuccari G; Villari D; Giuffrè G; Simone A; Squadrito G; Raimondo G; Barresi G
Histol Histopathol; 2002 Oct; 17(4):1077-83. PubMed ID: 12371135
[TBL] [Abstract][Full Text] [Related]
15. Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C.
Ferraro D; Bonura C; Giglio M; Di Stefano R; Almasio PL; Di Marco V; Craxì A; Cacciola I; Squadrito G; Raimondo G
J Biol Regul Homeost Agents; 2003; 17(2):172-5. PubMed ID: 14518718
[TBL] [Abstract][Full Text] [Related]
16. Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis.
Zignego AL; Fontana R; Puliti S; Barbagli S; Monti M; Careccia G; Giannelli F; Giannini C; Buzzelli G; Brunetto MR; Bonino F; Gentilini P
J Med Virol; 1997 Apr; 51(4):313-8. PubMed ID: 9093946
[TBL] [Abstract][Full Text] [Related]
17. Liver stellate cells in chronic viral hepatitis: the effect of interferon therapy.
Guido M; Rugge M; Chemello L; Leandro G; Fattovich G; Giustina G; Cassaro M; Alberti A
J Hepatol; 1996 Mar; 24(3):301-7. PubMed ID: 8778196
[TBL] [Abstract][Full Text] [Related]
18. Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C.
Fabris P; Brown D; Tositti G; Bozzola L; Giordani MT; Bevilacqua P; de Lalla F; Webster GJ; Dusheiko G
J Clin Virol; 2004 Mar; 29(3):160-6. PubMed ID: 14962784
[TBL] [Abstract][Full Text] [Related]
19. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
[TBL] [Abstract][Full Text] [Related]
20. Liver histology of children with chronic hepatitis treated with interferon-alpha alone or in combination with lamivudine.
Kuloglu Z; Krsaçloglu CT; Kansu A; Erden E; Girgin N
J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):564-8. PubMed ID: 18030234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
